Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004521

Director sold 2,000 shares at an average $66.56 ($133,122)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HERSHBERG ROBERT · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-15 Exercise or conversion : show line 1 in the form +2,000 $0.45 $900 2,000 D
2021-01-15 Sale : show line 2 in the form −1,378 $66.34 $91,417 622 D
2021-01-15 Sale : show line 3 in the form −622 $67.05 $41,705 0 D
Open-market sales · 2,000 sh · avg $66.56 · $133,122

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-15 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −2,000 57,000 D
Loading xslF345X03/doc4.xml…